Annals of Epidemiology
Volume 19, Issue 9 , Pages 647-650 , September 2009

Heterogeneity in Hepatitis B Virus (HBV) Seroprevalence Estimates from U.S. Adult Incarcerated Populations

  • Amy J. Harzke, DrPH

      Affiliations

    • Division of Epidemiology and Outcomes in Correctional Managed Care, University of Texas Medical Branch, Galveston
    • Corresponding Author InformationAddress correspondence and requests for reprints to: Dr. Amy Jo Harzke, Correctional Managed Care, University of Texas Medical Branch, 301 University Blvd., Mail Route 1008, Galveston, TX 77555.
    • ,
  • Karen J. Goodman, PhD

      Affiliations

    • Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Canada
    • ,
  • Patricia D. Mullen, DrPH

      Affiliations

    • Division of Behavioral Sciences and Health Promotion, School of Public Health, The University of Texas, Houston
    • ,
  • Jacques Baillargeon, PhD

      Affiliations

    • Division of Epidemiology and Outcomes in Correctional Managed Care, University of Texas Medical Branch, Galveston

Received 26 March 2009 ,Accepted 1 April 2009.

References 

  1. Centers for Disease Control and Prevention. Disease burden from viral hepatitis A, B, and C in the United States. 2002. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/resource/PDFs/disease_burden2004.pdf. Accessed October 1, 2004.
  2. Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA. Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations. JAMA. 1995;274:1201–1208
  3. McQuillan GM, Coleman PJ, Kruszon-Moran , Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United Status: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health. 1999;89:14–18
  4. Centers for Disease Control and Prevention . Protection against viral hepatitis: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1990;39(RR-2):1–26
  5. Centers for Disease Control and Prevention . Prevention and control of infections with hepatitis viruses in correctional settings. MMWR Recomm Rep. 2003;52(RR-1):1–44
  6. Centers for Disease Control and Prevention . A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP): Part 1: Immunization of Infants, Children, and Adolescents. MMWR Recomm Rep. 2005;54(RR-16):1–39
  7. Centers for Disease Control and Prevention . Hepatitis Surveillance Report No. 60. Atlanta (GA): US Department of Health and Human Services, Centers for Disease Control and Prevention; 2005;
  8. Koplan JP, Walker JA, Bryan JA, Berquist KR. Prevalence of hepatitis B surface antigen and antibody at a state prison in Kansas. J Infect Dis. 1978;137:505–506
  9. Kibby T, Devine J, Love C. Prevalence of hepatitis B among men admitted to a federal prison. N Engl J Med. 1982;306:175
  10. Bader T. Hepatitis B carriers in the prison population. N Engl J Med. 1983;308:281
  11. Kaufman ML, Faiver KL, Harness JK. Hepatitis B markers among Michigan prisoners. Ann Intern Med. 1983;98:558
  12. Decker MD, Vaughn WK, Brodie JS, Hutcheson RH, Schaffner W. Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis. 1984;150:450–459
  13. Anda RF, Perlman SB, D'Alessio DJ, Davis JP, Dodson VN. Hepatitis B in Wisconsin male prisoners: considerations for serologic screening and vaccination. Am J Public Health. 1985;75:1182–1185
  14. Brewer F. Hepatitis B–Similarity of risk among populations. J Pris Jail Health. 1985;5:102–107
  15. Hull HF, Lyons LH, Mann JM, Hadler SC, Steece R, Skeels MR. Incidence of hepatitis B in the penitentiary of New Mexico. Am J Public Health. 1985;75:1213–1214
  16. Bader T, Kibby T, Mueller M, Love C, Khayrallah M, Ham R. Hepatitis-B in United States prisoners. J Med Virol. 1987;21:A4–A4
  17. Tucker RM, Gaffey MJ, Fisch MJ, Kaiser DL, Guerrant RL, Normansell DE. Seroepidemiology of hepatitis D (delta agent) and hepatitis B among Virginia state prisoners. Clin Ther. 1987;9:622–628
  18. Andrus JK, Fleming DW, Knox C, McAlister RO, Skeels MR, Conrad RE, et al. HIV testing in prisoners: is mandatory testing mandatory?. Am J Public Health. 1989;79:840–842
  19. Barry MA, Gleavy D, Herd K, Schwingl PJ, Werner BG. Prevalence of markers for hepatitis B and hepatitis D in a municipal house of correction. Am J Public Health. 1990;80:471–473
  20. Smith PF, Mikl J, Truman BI, Lessner L, Lehman JS, Stevens RW, et al. HIV infection among women entering the New York state correctional system. Am J Public Health. 1991;81(Suppl):35–40
  21. Minshall ME, Dickinson DJ, Fleissner ML. Prevalence of syphilis, hepatitis B virus (HBV), and human immunodeficiency virus (HIV) infection in new arrestees at the Lake County Jail, Crown Point, Indiana. J Pris Jail Health. 1993;12:135–155
  22. Ruiz JD, Mikanda J. Seroprevalence of HIV, hepatitis B, hepatitis C, and risk behaviors among inmates entering the California correctional system. Sacramento, California: Department of Health Services; 1996. Available at: http://www.dhs.ca.gov/ps/ooa/Reports/PDF/Corrections99.pdf. Accessed August 1, 2004.
  23. Ruiz JD, Chang JS, Bernstein K, Chow JM, Bolan G, Pettifor A, Parikh-Patel A, Moliter F. Prevalence of HIV infection, sexually transmitted diseases, hepatitis, and risk behaviors among inmates entering prison at the California Department of Corrections; 1999. Sacramento: Department of Health Services; 2001. Available at: http://www.dhs.ca.gov/ps/ooa/Reports/PDF/1996SeroofHIVHepBHepCandRiskAmongInmates.pdf. Accessed August 1, 2004.
  24. Macalino GE, Rich JD, Sandford-Colby S, Salas CM, Vlahov D. Intake prevalence and intraprison incidence of HIV, hepatitis B (HBV), and hepatitis C (HCV) among sentenced inmates in Rhode Island, USA. International Conference on AIDS; Abstract 9208; July 7-12, 2002; Barcelona, Spain.
  25. Centers for Disease Control and Prevention . Hepatitis B vaccination of inmates in correctional facilities–Texas, 2000-2002. MMWR Morb Mortal Wkly Rep. 2004;53:681–683
  26. Centers for Disease Control and Prevention . Transmission of hepatitis B virus in correctional facilities–Georgia, January 1999-June 2002. MMWR Morb Mortal Wkly Rep. 2004;53:678–681
  27. Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;94:1218–1223
  28. Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health. 2004;81:25–37
  29. Khan AJ, Simard EP, Bower WA, Wurtzel HL, Khristova M, Wagner KD, et al. Ongoing transmission of hepatitis B virus infection among inmates at a state correctional facility. Am J Public Health. 2005;95:1793–1799
  30. Macalino GE, Vlahov D, Dickinson BP, Schwartzapfel B, Rich JD. Community incidence of hepatitis B and C among reincarcerated women. Clin Infect Dis. 2005;41:998–1002
  31. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from U.S. correctional facilities, 1997. Am J Public Health. 2002;92:1789–1794
  32. Harrison PM, Beck AJ. Prisoners in 2002. Bur Justice Stat Bull. 2003. NCJ. 2002;48:1–14Available at: http://www.ojp.usdoj.gov/bjs/pubalp@.htm#PAccessed October 15, 2004
  33. Harrison PM, Karberg JC. Prison and jail inmates at midyear 2003. Bur Justice Stat Bull. 2004;NCJ 203947:1–14. Available at: http://www.ojp.usdoj.gov/bjs/pubalp@.htm#P. Accessed October 15, 2004.
  34. Beck AJ, Maruschak LM. Hepatitis testing and treatment in state prisons. Bur Justice Stat Bull. 2004; NCJ 199173C. Available at: http://www.ojp.usdoj.gov/bjs/pub/pdf/httsp.pdf. Accessed October 30, 2004.
  35. Loney PL, Chambers LW, Bennett KJ, Roberts JG, Stratford PW. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can. 1998;19:170–176
  36. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008–2012
  37. Harzke AJ. Hepatitis B and C infections in U.S. Incarcerated Populations: Prevalence and Related Mortality [Dr. P.H. dissertation]. Houston (TX): University of Texas School of Public Health; 2007;
  38. Statistics/Data Analysis, version 8.2. College Station (TX): StataCorp; 1984-2003;
  39. Brown LD, Cai TT, Das Gupta A. Interval estimation for a binomial proportion. Stat Sci. 2001;16:101–133
  40. Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oaks (CA): Sage Publications; 2001;
  41. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In:  Egger M,  Smith GD,  Altman DG editor. Systematic reviews in health care: meta-analysis in context. London: BMJ Publishing Group; 2001;p. 285–312
  42. Greenland S. Meta-analysis. In:  Rothman KJ,  Greenland S editor. Modern epidemiology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1998;p. 643–673
  43. Benjamin DK, Poole C, Steinbach WJ, Rowen JL, Walsh TJ. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics. 2003;112:634–640
  44. Thompson SG. Why and how sources of heterogeneity should be investigated. In:  Egger M,  Smith GD,  Altman DG editor. Systematic reviews in health care: meta-analysis in context. London: BMJ Publishing Group; 2001;p. 157–175
  45. Hamilton LC. Statistics with Stata: Updated for Version 8. Belmont (CA): Brooks/Cole-Thomson Learning. 2004;

PII: S1047-2797(09)00115-X

doi: 10.1016/j.annepidem.2009.04.001

Annals of Epidemiology
Volume 19, Issue 9 , Pages 647-650 , September 2009

Article Tools

* Image Usage & Resolution